StoneWise
望石智慧
elsewhere's corpus does not cover StoneWise as a subject in its own right. The only material that mentions the company is background context in pieces about its investors: Heart Capital led a Series B in the AI-driven drug-discovery firm, and Linear Capital also holds a stake that was recognized in a ChinaVenture 2023 best-investment-case list . No chunk in the bundle is actually about StoneWise itself, so elsewhere cannot profile who founded it, when it was established, its pipeline, or its current standing.
AI-generated — may contain errors, please verify.
Coverage
Spring has arrived — can blossoms be far behind? | Linear Quarterly
Rather than waiting for spring, define it.
线性资本·The First Newsletter of Autumn | Linear Quarterly
Cycles turn, and Wanwu Capital begins to harvest.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier technology and innovation fund.
线性资本·Linear Capital received honors including "Top 8 Best Early-Stage VC Firms" and "Best Investment Firm in China's AI and Big Data Industry" from ChinaVenture.
On May 19, ChinaVenture released its 2022 annual rankings of Chinese venture capital and private equity investment institutions — the ChinaVenture Awards. **Linear Capital was named among the "Top 8 Best Early-Stage VC Firms in China" and received the "Top 20 Best Investment Firms in China's AI and Big Data Sector" award, among other honors**.
线性资本·
